Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Amyloid Fibrils03:03

Amyloid Fibrils

9.6K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Protein Folding01:25

Protein Folding

8.1K
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
8.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

MIL-88A(Fe)-derived Co<sub>9</sub>S<sub>8</sub>/Fe<sub>2</sub>O<sub>3</sub> nanotubes: Construction of Schottky junction for enhanced pesticide removal.

Journal of environmental management·2026
Same author

Short-term photovoltaic power forecasting using DTW-based K-Medoids clustering and a hybrid VMD-CEEMDAN-1DCNN-S-Mamba model.

Scientific reports·2026
Same author

A Comprehensive Comparison of Transition Point Detection Methods for Monkeypox - Africa, 2024-2025.

China CDC weekly·2026
Same author

The Prognostic Nutritional Index Serves as a Novel and Independent Predictor of Recurrence in Patients with Non-Muscle-Invasive Bladder Cancer.

Nutrition and cancer·2026
Same author

Synthesis, characterization and antitumor activity of novel glycyrrhetinic acid derivatives.

Journal of Asian natural products research·2026
Same author

A case report of a giant left atrial myxoma traversing a patent foramen ovale as a biatrial myxoma.

BMC cardiovascular disorders·2026

相关实验视频

Updated: Jul 16, 2025

A11-positive &#946;-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

12.0K

为了最大限度地控制粉样纤维化.

Mengshou Wang1, Gao Li2,3, Liangrong Peng4

  • 1School of Mathematics, Sun Yat-sen University, Guangzhou, 510275, People's Republic of China.

Bulletin of mathematical biology
|September 9, 2023
PubMed
概括

这项研究优化了针对粉样纤维化症的表甲基素-3-酸盐剂量,发现多剂量适合长期治疗,单次高剂量适合短期需求.

关键词:
粉样纤维化是粉样纤维化的.抑制抑制的抑制作用最佳的控制控制是最好的控制.庞特里亚金的最大原则是精确的剂量定量方法

更多相关视频

Analysis of &#946;-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.3K
Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
08:53

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids

Published on: March 21, 2025

807

相关实验视频

Last Updated: Jul 16, 2025

A11-positive &#946;-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

12.0K
Analysis of &#946;-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.3K
Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
08:53

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids

Published on: March 21, 2025

807

科学领域:

  • 生物化学和药物化学 医学化学
  • 药理学和制药科学 药理学和制药科学
  • 计算生物学 计算生物学

背景情况:

  • 粉样纤维化是神经退行性疾病的一个关键过程.
  • 乙甲基-3-酸盐 (EGCG) 通过降解纤维而显示出作为粉样蛋白抑制剂的潜力.
  • 对EGCG的最佳剂量策略仍未得到充分研究,这阻碍了临床应用.

研究的目的:

  • 为了确定 epigallocatechin-3-gallate (EGCG) 抑制粉样纤维化的最佳剂量策略.
  • 为了平衡EGCG的治疗疗效和潜在毒性,使用最佳控制理论.
  • 将建议的最佳控制策略与传统的剂量方法进行比较.

主要方法:

  • 采用了针对粉样纤维化和抑制的通用后勤模型.
  • 应用最佳控制理论来获得用于抑制剂剂量的分析溶液.
  • 系统地将最佳控制轨迹与传统药物剂量策略进行比较.
  • 通过实验比较验证了发现.

主要成果:

  • 为EGCG的最佳控制轨迹获得了分析解决方案.
  • 证明多次剂量管理是长期粉样蛋白疾病治疗的最佳方法.
  • 确定单次高剂量疗法作为短期治疗方案的首选.
  • 展示了模型参数对最佳剂量策略的影响.

结论:

  • 这项研究为优化amyloid抑制EGCG剂量的理论框架.
  • 结果表明根据治疗持续时间,量身定制的剂量策略 (多次或单次高剂量).
  • 这项研究有助于像EGCG这样的粉样蛋白抑制剂的合理临床应用.